Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.
- NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_assertion wasGeneratedBy ECO_0000203 NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.
- NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_assertion wasDerivedFrom befree-20150227 NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.
- NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_assertion SIO_000772 14625284 NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.
- NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_assertion evidence source_evidence_literature NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.
- NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_assertion description "[siRNA-mediated gene silencing of Her-2/neu and increasing the expression of thrombospondin-1 may be a useful therapeutic strategy for Her-2/neu-over-expressing breast or ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736299.RAA2KvPcaEiTsPgDAiPkAoGg2mhhp_qAPDoNYSsWMG1lM130_provenance.